<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Data from 14 patients with benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (<z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>) have been analyzed using a nonlinear least-squares regression model which was developed and programmed from in-hospital microcomputer use </plain></SENT>
<SENT sid="1" pm="."><plain>The method of analysis permits rapid estimation of cerebrospinal fluid (CSF) formation and absorption rates as functions of pressure in individual patients using data from constant-rate infusion manometrics </plain></SENT>
<SENT sid="2" pm="."><plain>The analysis predicts that <z:chebi fb="0" ids="8382">prednisone</z:chebi> therapy in <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> reduces resting CSF pressure by increasing CSF absorption at <z:hpo ids='HP_0000001'>all</z:hpo> intracranial pressures studied, and decreasing CSF formation at high pressures </plain></SENT>
<SENT sid="3" pm="."><plain>This result is in accordance with evidence suggesting that impaired CSF absorption plays a major role in the pathogenesis of <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> in <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> </plain></SENT>
</text></document>